Interesting that they have treating the first patient in the EMD AML trial as an upcoming catalyst in H2CY2023…….I thought this trial was put on ice by DCB as he was trying to pivot to multiple R/R AML trials instead as per his revised strategy?
Since this is paid research by RACE Oncology, @Davisite are you able to clarify if this is up to date and accurate?
RAC media coverage, page-1706
-
- There are more pages in this discussion • 580 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.94 |
Change
0.055(2.92%) |
Mkt cap ! $330.4M | |||
| Open | High | Low | Value | Volume |
| $1.89 | $1.96 | $1.85 | $333.0K | 174.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3105 | $1.94 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.95 | 7574 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |